R&D Systems™ Recombinant Human TAFA3/FAM19A3 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human TAFA3/FAM19A3 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q7Z5A8
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS
• Gene ID (Entrez): 284467
• Molecular Weight (g/mol): 11kDa
• Name: TAFA3/FAM19A3
• Preparation Method: Reconstitute at 400μg/mL in sterile PBS.
• Quality Control Testing: SDS-PAGE: 10kDa, reducing conditions
• Quantity: 50 μg
• Source: E. coli-derived human TAFA3/FAM19A3 protein Ala31-Arg133
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Ala31
• Without Additives: Carrier Protein
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE with silver staining